A world leader in the science industry is expanding their company and opening a new facility in Northern Kentucky.
Thermo Fisher Scientific Inc., whose global team is dedicated to advancing healthcare through various research and lab activity, recently announced plans to locate a new lab operation in Covington.
Advancing Patient Safety
The company plans to expand its laboratory operations in Kentucky, whose pharmaceutical work focuses on providing safe, effective medicines to patients.
The PPD clinical research business of Thermo Fischer Scientific will expand its sample management and biorepository operations in a new 65,000-square-foot space in Covington, enabling further capability at its existing site in nearby Highland Heights.
Thermo Fisher’s nearly $48 million investment is expected to create more than 250 new jobs across the two sites over the next eight years, with 69 of those being Kentucky jobs.
“Our central lab plays a vital role in helping our customers make timely, efficient and informed decisions about their clinical trials and ensure patient safety,” said Leon Wyszkowski, President of the Analytical Services Division at Thermo Fisher Scientific. “Our expansion will enhance their ability to advance life-changing research. We are excited to expand into Covington and grow our operations in Highland Heights as a vital part of our global labs capabilities serving our customers. We value the support of state and local officials as we continue to hire talented colleagues to advance our company’s mission to enable our customers to make the world healthier, cleaner and safer.”
The business has operated a central lab operation in Highland Heights since 2002.
Today the facility includes central lab services, biomarker operations, sample management and testing to support new therapeutics, including vaccines and cell and gene therapy products.
The renovation of an existing building on West 38th Street in Covington will significantly expand the business’ labs footprint.
Performing Clinical Research
The PPD clinical research business provides global contract research services to pharmaceutical, biotech, medical device and academic organizations.
The business’ clinical development offerings include clinical trial services spanning early to late-stage trials, as well as peri- and post-approval research, while laboratory services include advanced lab testing and central lab services.
The company’s clinical research business has conducted trials in more than 100 countries.
“The commonwealth is seeing tremendous growth in its health care and life sciences sectors, providing high-paying, quality jobs for Kentucky residents across the state,” said Governor Andy Beshear. “I am thrilled to see Thermo Fisher once again choosing Kentucky to locate and expand its business. I look forward to the company’s continued success here in the commonwealth as this investment adds to Northern Kentucky’s economic growth.”
Renovation and construction of the new facility is anticipated to begin later this year.
For more information, visit thermofisher.com.
